Medical Devices Startups

Ascendia Pharmaceutical Solutions is a contract development and manufacturing organization (CDMO) that provides formulation, nanotechnology, and manufacturing services for pharmaceutical and biological companies from pre-formulation through commercialization. The company specializes in solving drug development challenges for small molecules, biologics, and gene delivery applications.

1 investor

Asclepii makes Poseidon, an FDA-cleared nanosilver hydrogel wound dressing that maintains a moist wound environment and blocks microbes for topical wound management. It is used by clinicians such as podiatrists and nurses for chronic and everyday wound care.

1 investor

Asclepius MedTech develops remote patient monitoring systems for pre- and post-surgical care. The company is advised by medical professionals including orthopaedic surgeons.

1 investor

ASEM Technology develops a non-invasive measurement platform based on the ASEM method (acousto-electromagnetic method), which uses ultrasound to detect electric and magnetic polarization inside materials and visualize qualitative degradation or alteration. The technology, originating from research at Tokyo University of Agriculture and Technology, targets medical and healthcare applications (including a next-generation diagnostic device that visualizes and quantifies collagen fiber orientation and accumulation) and advanced non-destructive testing in industry.

1 investor

Ason develops wearable medical sensors and devices based on soft electronics, including sensors that measure tissue oxygen levels, detect pressure ulcers, and continuously monitor blood glucose. The South Korea-based company also builds electroceutical patches for chronic wound healing, serving the medical and patient-care market.

1 investor

Ashlins Pharmaceuticals develops therapeutics for rare and underserved diseases, focusing on programs with scientific validation and accelerated regulatory pathways to deliver treatments where patient options are limited.

1 investor

Asieris (亚虹医药) is a pharmaceutical company developing diagnostic and therapeutic products focused on women's reproductive health and urologic cancers, including treatments for cervical precancerous lesions and bladder cancer. Its portfolio includes a non-invasive portable cervical photodynamic therapy product and a blue-light cystoscopy system for bladder cancer diagnosis, marketed in China.

1 investor

Asima Health is developing a non-invasive, multi-cancer blood test that uses a pan-genomic platform to detect multiple cancers from a single blood draw. The portable technology is intended for use through local diagnostic labs as part of routine blood work to identify people at risk who may need further screening.

1 investor

AskAt is a pharmaceutical company focused on developing new drugs with novel mechanisms for conditions that lack effective treatments, such as cancer, dementia, and autoimmune diseases. It aims to bring these therapies to patients worldwide.

1 investor

AspiAir is a clinical-stage biotech company developing LASAG Inhale, an inhaled non-opioid treatment for pain and migraine attacks using acetylsalicylic acid. The company serves patients in the EU who lack access to adequate migraine medications and aims to provide a safe, mobile alternative to current therapies.

1 investor

AviadoBio is a biotech company focused on frontotemporal dementia (FTD), a form of early-onset dementia. The company engages with patients, families, and caregivers affected by FTD to develop treatment solutions.

1 investor

Aspisafe Safe Solutions develops medical devices in the hospital medicine space, including products related to NG (nasogastric) tube safety. The company operates in the medical device and healthcare sector.

1 investor

Aspivix is a healthcare company focused on women's health, using storytelling and engagement to reimagine care delivery and patient experience.

1 investor

ATDev builds assistive robotic technology for people with mobility and rehabilitation needs, including Reflex, a telehealth-enabled robotic device for orthopedic knee recovery, and RAMMP, a robotic assistive mobility and manipulation wheelchair platform. Its products serve individuals seeking greater independence in the medical device and assistive technology category.

1 investor

iAssist is a specialty therapy initiation platform that helps patients access prescribed therapies by reducing administrative delays and improving communication between patients, healthcare providers, and manufacturers. The platform serves nurses, healthcare practices, and oncology drug manufacturers in the specialty pharmaceutical sector.

1 investor

AMFT is a global platform for precision metal forming and custom-engineered solutions, serving nine end markets including aerospace, defense, medical devices, and transportation. The company operates manufacturing sites across the Americas, Europe, and Asia-Pacific, specializing in coiling, stamping, wire forming, and deep-drawn components.

1 investor

Asteres builds ScriptCenter automated kiosks and lockers that let patients pick up pharmacist-filled prescriptions and healthcare products securely at any hour, while pharmacy staff retain control over filling and checking. Its self-service pharmacy pickup systems serve retail pharmacy, healthcare, and U.S. Department of Defense and Veterans Affairs markets.

1 investor

Astraea provides clinical trial automation software for pharmaceutical sponsors that uses AI to automate post-protocol tasks including statistical analysis plans, case report forms, datasets, regulatory documentation, and FDA submissions. The platform is deployed within the sponsor's own environment to maintain data security and compliance across oncology, rare disease, and medical devices.

1 investor

Astratus develops a semi-automated laboratory platform using a microcapillary "dip and test" cassette and instrument reader for rapid antimicrobial susceptibility testing (AST), delivering results in under 6 hours directly from urine or bacterial isolates. It serves human, veterinary, and research markets, supporting clinical laboratories with antimicrobial stewardship and researchers developing new antimicrobials and therapies.

1 investor

Astraveus develops the Lakhesys Benchtop Cell Factory, a microfluidic-based bioprocessing platform for scaling cell and gene therapy manufacturing with improved quality and cost efficiency. The company serves biotech and pharma organizations working on cell therapy manufacturing and commercialization.

1 investor

Astro Shapes manufactures custom-finished aluminum extrusions for industrial and commercial markets that require high quality and specialized finishing. Founded in 1971 and based in Ohio, the company is a regional leader focused on operational excellence and customer service.

1 investor

Asvin Tech develops DENTRA, an AI-powered intraoral 3D scanning platform for dentists that automates dental workflows including oral impressions, product fabrication, and lab coordination. The platform connects dentists with partner dental labs, providing real-time updates, quality control, and reduced costs for dental treatment.

1 investor

Atanis Biotech develops FAST-PASE®, a blood-based allergy diagnostic test that measures how a patient's blood activates mast cells in response to specific food and other allergens, avoiding skin pricks and food challenges. The test targets common food allergens (egg, milk, peanut, cashew) and Alpha-gal red meat allergy, and is currently in development for use by patients and healthcare providers.

1 investor

Atelerix Life Sciences develops novel respiratory therapies for drug-induced respiratory depression, respiratory disease exacerbations, and bio-defense against respiratory threats. The company is advancing pre-clinical and clinical-stage drug candidates, with ATLX-0199 as its lead compound designed to stimulate respiratory drive while preserving pain relief and sedation.

1 investor